| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 25 |
| 1 | DEXAMETHASONE | 21 |
| 2 | DEXAMETHASONE 1.5 MG | 21 |
| 3 | RITUXIMAB | 21 |
| 4 | MYCOPHENOLATE MOFETIL | 19 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 19 |
| 6 | INFLIXIMAB | 14 |
| 7 | FOLIC ACID | 8 |
| 8 | LEVETIRACETAM | 8 |
| 9 | METHOTREXATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 1 | WHITE PETROLATUM | 1 | 0.0007 |
| 2 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 3 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 4 | MITOXANTRONE HYDROCHLORIDE | 3 | 0.0005 |
| 5 | GOLIMUMAB | 5 | 0.0004 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 7 | BARICITINIB | 1 | 0.0003 |
| 8 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 9 | PHENAZOPYRIDINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 36 |
| 1 | Integrin Receptor Antagonist [EPC] | 26 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 5 | Vitamin D [EPC] | 10 |
| 6 | Proton Pump Inhibitor [EPC] | 9 |
| 7 | Vitamin B12 [EPC] | 9 |
| 8 | Vitamin C [EPC] | 9 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 2 | Integrin Receptor Antagonist [EPC] | 26 | 0.0003 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 5 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 8 | 0.0001 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 24 | 0.0001 |